Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate

Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate

US Patent 11141413 · Granted Oct 12, 2021

Estimated economic value: $64,499,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline Solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-f2025
Liquid dosage forms to treat cancer2024
Liquid dosage forms to treat cancer2024
Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-2023
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-f2023
Liquid dosage forms to treat cancer2022
Liquid dosage forms to treat cancer2022
Method of treating cancer and bone cancer pain2022
Method of treating cancer and bone cancer pain2022
Methods of using c-Met modulators2022
Combinations of cabozantinib and atezolizumab to treat cancer2021
Combinations of cabozantinib and atezolizumab to treat cancer2021